Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMahidol University
About this trial
A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients
Eligibility criteria
Qualifiers
breast cancer patients with starting adjuvant aromatase inhibitor within 4 weeks
able to read and write
Disqualifiers
chronic arthritis
history of heart failure or acute coronary syndrome within 6 months
individuals who exercises regularly more than 150 minutes/week
Trial design
Treatments tested in this trial
- tailored exercise
Treatment groups
206 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mahidol University
Lead sponsor
Siriraj Hospital
Sponsor institution
Source ClinicalTrials.gov